Rocket


Overview
Financials
News + Filings

 
 

Milestone Pharmaceuticals Inc. Add to portfolio


Recent News + Filings   (All items)

Financial Summary   (All financials)
In millions, except per share itemsDec-31-18Dec-31-17
Revenues23.88.3
            Revenue growth188.1% 
Cost of goods sold23.88.3
Gross profit0.00.0
            Gross margin0.0%0.0%
General and administrative3.11.5
EBIT-23.8-8.3
            EBIT margin-100.0%-100.0%
Pre-tax income0.00.0
Income taxes0.10.0
Net income0.00.0
            Net margin0.0%0.0%
 
Diluted EPS$0.00 
Shares outstanding (diluted)0.0 
 
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.

Rocket Data Systems, Inc. © 2018 | Contact Us | Data Disclaimer | Terms of Use | Privacy